Open Access<p>Circ_0110805 Knockdown Enhances Cisplatin Sensitivity and Inhibits Gastric Cancer Progression by miR-299-3p/ENDOPDI Axis</p>
Author(s) -
Xi Yang,
Qunxiong Zhang,
Bugao Guan
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s279563
Subject(s) - cisplatin , gene knockdown , cancer , cancer research , downregulation and upregulation , viability assay , apoptosis , cancer cell , medicine , chemistry , oncology , chemotherapy , gene , biochemistry
Gastric cancer is a prevalent primary stomach tumor. Cisplatin is frequently used to treat gastric cancer. However, the resistance of cisplatin in gastric cancer often occurs, which brings a heavy burden to gastric cancer treatment.